Back to funds
View filing
Rubric Capital Management LP
hedge fundUpdated 27 days agoManaged by Rubric Capital Management Lp • Latest filing Q2 2026
Portfolio value
$10.9B
Q2 2026
Filings
14
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
-86.5%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 14 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q1 2023 | $3.9B |
| Q2 2023 | $2.3B |
| Q3 2023 | $2.7B |
| Q4 2023 | $4.8B |
| Q1 2024 | $3.4B |
| Q2 2024 | $3.8B |
| Q3 2024 | $6.1B |
| Q4 2024 | $7.8B |
| Q1 2025 | $5.6B |
| Q2 2025 | $6.6B |
| Q3 2025 | $8.9B |
| Q4 2025 | $8.4B |
| Q1 2026 | $9.4B |
| Q2 2026 | $10.9B |
Top holdings
87 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | T TLN TALEN ENERGY CORP | $1.4B | 3.60M | 12.70% | — |
| 2 | F FTAIM FTAI AVIATION LTD | $811.6M | 3.00M | 7.45% | — |
| 3 | V VTRS VIATRIS INC | $542.6M | 34.17M | 4.98% | — |
| 4 | T TEVJF TEVA PHARMACEUTICAL INDS LTD | $527.7M | 15.57M | 4.84% | — |
| 5 | G GLNG GOLAR LNG LTD | $457.5M | 9.18M | 4.20% | — |
| 6 | V VST VISTRA CORP | $284.7M | 1.79M | 2.61% | — |
| 7 | T TACPF TRANSALTA CORP | $279.8M | 20.23M | 2.57% | — |
| 8 | F FLR FLUOR CORP | $262.9M | 5.02M | 2.41% | — |
| 9 | K KNSA KINIKSA PHARMACEUTICALS INTL | $255.8M | 4.00M | 2.35% | — |
| 10 | B BGC BGC GROUP INC | $254.4M | 23.80M | 2.33% | — |
| 11 | Z ZM ZOOM COMMUNICATIONS INC | $238.7M | 2.77M | 2.19% | — |
| 12 | G GIL GILDAN ACTIVEWEAR INC | $232.2M | 4.50M | 2.13% | — |
| 13 | A ARQT ARCUTIS BIOTHERAPEUTICS INC | $216.9M | 8.27M | 1.99% | — |
| 14 | A AMZN AMAZON COM INC | $214.5M | 900.0K | 1.97% | — |
| 15 | R ROIV ROIVANT SCIENCES LTD | $212.3M | 6.00M | 1.95% | — |
| 16 | Z ZYME ZYMEWORKS INC | $183M | 7.00M | 1.68% | — |
| 17 | A AMCCF AMCOR PLC | $180.4M | 4.16M | 1.66% | — |
| 18 | C CMPR CIMPRESS PLC | $178M | 1.75M | 1.63% | — |
| 19 | A AMRX AMNEAL PHARMACEUTICALS INC | $176M | 10.17M | 1.61% | — |
| 20 | N NRIX NURIX THERAPEUTICS INC | $175.3M | 7.23M | 1.61% | — |